Patents by Inventor Cédric Poinsard

Cédric Poinsard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10202346
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: February 12, 2019
    Assignee: Galderma Research & Development
    Inventors: Cedric Poinsard, Pascal Collette, Pascale Mauvais, Jean-Michel Linget, Sandrine Rethore
  • Patent number: 9732044
    Abstract: The present invention relates generally to the field of pharmaceuticals and cosmetics. More specifically, the present invention pertains to certain N-(pyrid-4-yl)amides and N-(pyrimidin-4-yl)amides of the following formula which are potent modulators (e.g., inhibitors) of an androgen receptor, and which are useful, for example, in therapy, for example, in the treatment of a dermatological disease or disorder; a disease or disorder of the sebaceous gland(s); acne; hyperseborrhoea; oily skin; seborrhoeic dermatitis; hyperpilosity or hirsutism; atopic dermatitis; or androgenic alopecia; especially acne. The present invention also relates to compositions (e.g., pharmaceutical compositions, cosmetic compositions) comprising the compounds; methods of preparing the compositions; methods of modulating (e.g., inhibiting) an androgen receptor using the compounds and/or compositions; and medical and/or cosmetic use of the compounds and compositions.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: August 15, 2017
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventor: Cédric Poinsard
  • Publication number: 20170066725
    Abstract: The present invention relates generally to the field of pharmaceuticals and cosmetics. More specifically, the present invention pertains to certain N-(pyrid-4-yl)amides and N-(pyrimidin-4-yl)amides of the following formula which are potent modulators (e.g., inhibitors) of an androgen receptor, and which are useful, for example, in therapy, for example, in the treatment of a dermatological disease or disorder; a disease or disorder of the sebaceous gland(s); acne; hyperseborrhoea; oily skin; seborrhoeic dermatitis; hyperpilosity or hirsutism; atopic dermatitis; or androgenic alopecia; especially acne. The present invention also relates to compositions (e.g., pharmaceutical compositions, cosmetic compositions) comprising the compounds; methods of preparing the compositions; methods of modulating (e.g., inhibiting) an androgen receptor using the compounds and/or compositions; and medical and/or cosmetic use of the compounds and compositions.
    Type: Application
    Filed: August 15, 2016
    Publication date: March 9, 2017
    Inventor: Cédric POINSARD
  • Publication number: 20170037015
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 9, 2017
    Inventors: Cédric POINSARD, Pascal COLLETTE, Jean-Michel LINGET, Sandrine RETHORE, Pascale MAUVAIS
  • Patent number: 9505720
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: November 29, 2016
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Pascal Collette, Jean-Michel Linget, Sandrine Rethore, Pascale Mauvais
  • Patent number: 9452120
    Abstract: N-(pyrid-4-yl)amides and N-(pyrimidin-4-yl)amides of formula (1) are described that are potent modulators (e.g., inhibitors) of an androgen receptor, and which are useful, for example, in the treatment of a dermatological disease or disorder; a disease or disorder of the sebaceous gland(s); acne; hyperseborrhoea; oily skin, seborrhoeic dermatitis; hyperpilosity or hirsutism; atopic dermatitis; or androgenic alopecia; especially acne. Also described, are compositions (e.g., pharmaceutical compositions, cosmetic compositions) comprising the compounds; methods of preparing the compositions; methods of modulating (e.g., inhibiting) and androgen receptors using the compounds and/or compositions; and medical and/or cosmetic use of the compounds and compositions.
    Type: Grant
    Filed: November 5, 2012
    Date of Patent: September 27, 2016
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventor: Cédric Poinsard
  • Publication number: 20160115132
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Application
    Filed: May 8, 2015
    Publication date: April 28, 2016
    Inventors: Cédric POINSARD, Pascal COLLETTE, Jean-Michel LINGET, Sandrine RETHORE, Pascale MAUVAIS
  • Publication number: 20160068488
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Application
    Filed: July 27, 2015
    Publication date: March 10, 2016
    Inventors: Cedric POINSARD, Pascal COLLETTE, Pascale MAUVAIS, Jean-Michel LINGET, Sandrine RETHORE
  • Patent number: 9120753
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: September 1, 2015
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Patrice Lucien Maurice Collette, Isabelle Marie Joëlle Martine Collette, Pascale Mauvais, Jean-Michel Linget, Sandrine Rethore
  • Patent number: 9050266
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: June 9, 2015
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Jean-Michel Linget, Sandrine Rethore, Pascale Mauvais, Patrice Lucien Maurice Collette, Isabelle Marie Joëlle Martine Collette
  • Publication number: 20140275536
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Application
    Filed: December 22, 2010
    Publication date: September 18, 2014
    Applicant: Galderma Research & Development
    Inventor: Cédric Poinsard
  • Publication number: 20140234245
    Abstract: N-(pyrid-4-yl)amides and N-(pyrimidin-4-yl)amides of formula (1) are described that are potent modulators (e.g., inhibitors) of an androgen receptor, and which are useful, for example, in the treatment of a dermatological disease or disorder; a disease or disorder of the sebaceous gland(s); acne; hyperseborrhoea; oily skin, seborrhoeic dermatitis; hyperpilosity or hirsutism; atopic dermatitis; or androgenic alopecia; especially acne. Also described, are compositions (e.g., pharmaceutical compositions, cosmetic compositions) comprising the compounds; methods of preparing the compositions; methods of modulating (e.g., inhibiting) and androgen receptors using the compounds and/or compositions; and medical and/or cosmetic use of the compounds and compositions.
    Type: Application
    Filed: November 5, 2012
    Publication date: August 21, 2014
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventor: Cédric Poinsard
  • Publication number: 20130178633
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Application
    Filed: December 22, 2010
    Publication date: July 11, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Pascale Mauvais, Jean-Michel Linget, Sandrine Rethore, Patrice Lucien Maurice Collette, Isabelle Marie Joëlle Martine Collette
  • Publication number: 20130172564
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Application
    Filed: December 22, 2010
    Publication date: July 4, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Jean-Michel Rethore, Patrice Lucien Maurice Collette, Isabelle Marie Joëlle Collette
  • Patent number: 8445523
    Abstract: SOAT-1 inhibitors of general formula (I) and cosmetic and pharmaceutical compositions containing such a compound are described.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: May 21, 2013
    Assignee: Galderma Research & Development
    Inventors: Laurence Dumais, Cédric Poinsard, Thibaud Portal
  • Patent number: 8420681
    Abstract: Compounds of general Formula (I), and cosmetic and pharmaceutical compositions containing such a compound are described.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: April 16, 2013
    Assignee: Galderma Research & Development
    Inventor: Cédric Poinsard
  • Patent number: 8420682
    Abstract: Compounds of general Formula (I), and cosmetic and pharmaceutical compositions including such a compound are described.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: April 16, 2013
    Assignee: Galderma Research & Development
    Inventors: Cédric Poinsard, Thibaud Portal
  • Publication number: 20130022644
    Abstract: Compounds of general Formula (I), and cosmetic and pharmaceutical compositions including such a compound are described.
    Type: Application
    Filed: February 26, 2010
    Publication date: January 24, 2013
    Inventors: Jean-Claude Pascal, Cédric Poinsard
  • Patent number: 8134007
    Abstract: The present invention relates to compounds of the formula (I): and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.
    Type: Grant
    Filed: May 2, 2008
    Date of Patent: March 13, 2012
    Assignee: Pfizer Inc.
    Inventors: Sharanjeet Kaur Bagal, Karl Richard Gibson, Mark Ian Kemp, Cedric Poinsard, Blanda Luzia Stammen, Stephen Martin Denton, Melanie Susanne Glossop
  • Publication number: 20120052096
    Abstract: SOAT-1 inhibitors of general formula (I) and cosmetic and pharmaceutical compositions containing such a compound are described.
    Type: Application
    Filed: February 26, 2010
    Publication date: March 1, 2012
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Laurence Dumais, Cédric Poinsard, Thibaud Portal